Viatris Inc recalls
Viatris Inc is named on 6 recalls in Recall Relay's records since November 2023, from FDA (18 recalled products: FDA lists each product as its own recall); the most recent was October 1, 2026.
All 18 recalled products, newest first.
-
Class IIIofficial
Viatris, Inc. recalls Telmisartan and AmlodipineSuperpotent Drug: potential for the Telmisartan content in these lots to exceed specifications
-
Class IIofficial
Viatris, Inc. recalls Xanax XRFailed Dissolution Specifications
-
Class IIofficial
Viatris Inc recalls Cardura XL (doxazosin) extended release tablets 4 mgFailed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
-
Class IIofficial
Viatris Inc recalls Cardura XL (doxazosin) extended release tablets 8 mgFailed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.
-
Class IIofficial
Viatris Inc recalls Levothyroxine Sodium Tablets USPSuperpotent Drug and Subpotent Drug: potency failures obtained
-
Class IIofficial
Viatris Inc recalls Levothyroxine Sodium Tablets USPSuperpotent Drug and Subpotent Drug: potency failures obtained
-
Class IIofficial
Viatris Inc recalls Levothyroxine Sodium Tablets USPSuperpotent Drug and Subpotent Drug: potency failures obtained
-
Class IIofficial
Viatris Inc recalls Levothyroxine Sodium Tablets USPSuperpotent Drug and Subpotent Drug: potency failures obtained
-
Class IIofficial
Viatris Inc recalls Levothyroxine Sodium Tablets USPSuperpotent Drug and Subpotent Drug: potency failures obtained
-
Class IIofficial
Viatris Inc recalls Levothyroxine Sodium Tablets USPSuperpotent Drug and Subpotent Drug: potency failures obtained
-
Class IIofficial
Viatris Inc recalls Levothyroxine Sodium Tablets USPSuperpotent Drug and Subpotent Drug: potency failures obtained
-
Class IIofficial
Viatris Inc recalls Levothyroxine Sodium Tablets USPSuperpotent Drug and Subpotent Drug: potency failures obtained
-
Class IIofficial
Viatris Inc recalls Levothyroxine Sodium Tablets USPSuperpotent Drug and Subpotent Drug: potency failures obtained
-
Class IIofficial
Viatris Inc recalls Levothyroxine Sodium Tablets USPSuperpotent Drug and Subpotent Drug: potency failures obtained
-
Class IIofficial
Viatris Inc recalls Levothyroxine Sodium Tablets USPSuperpotent Drug and Subpotent Drug: potency failures obtained
-
Class IIofficial
Viatris Inc recalls Cardura XL (doxazosin) extended release tablets 4mgFailed Impurities/Degradation Specifications
-
Class IIofficial
Viatris Inc recalls Cardura XL (doxazosin) extended release tablets 8mgFailed Impurities/Degradation Specifications
-
Class IIIofficial
Viatris Inc recalls Valacyclovir Tablets USPFailed Tablet/Capsule Specifications: There is a potential for the imprint, M 122, to be missing on some tablets.
This page groups recalls by the company name the agency printed, so it can include different companies with similar names, and a recall may name a store or distributor rather than the maker. It counts the recalls in Recall Relay's records, not a company's whole history; an FDA recall that lists several products counts once. Open a recall to see its details and the agency's official notice, which is always the final word. Recall Relay isn't affiliated with any agency or with the companies named here.
Severity labels say where they come from: “official” is the agency's own class, “advisory” is based on the agency's safety warning, and “est. risk” is Recall Relay's estimate from the hazard description, not an agency classification.
Hear about the next one
Recall Relay can email you when a new recall mentions Viatris Inc or any words you choose. Start with a free key (no card needed), then set up alerts on your account page.
Get recall alerts